Wave’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Wave Life Sciences develops next-generation nucleic acid drugs that achieve high systemic bioavailability. Read more

Paul Bolno's photo - President & CEO of Wave

President & CEO

Paul Bolno

CEO Approval Rating

87/100

Founded:

2012

Status:

PublicNASDAQWVE

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Alnylam is one of Wave's top rivals. Alnylam's headquarters is in Cambridge, Massachusetts, and was founded in 2002. Like Wave, Alnylam also competes in the Pharmaceuticals industry. Alnylam generates 2,757% of Wave's revenue.

Axolabs has been one of Wave's top competitors. Axolabs was founded in 2000 in Kulmbach, Bavaria. Like Wave, Axolabs also operates in the Biotechnology field. Axolabs generates $7.5M less revenue than Wave.

Voyager Therapeutics is one of Wave's top competitors. Voyager Therapeutics was founded in Cambridge, Massachusetts} in 2014. Like Wave, Voyager Therapeutics also competes in the Biotechnology sector. Compared to Wave, Voyager Therapeutics generates $100.8M more revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Arrowhead a competitor of Wave?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$12.5M

Wave's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 2.1B. Over the last four quarters, Wave's revenue has grown by 3.3%. Specifically, in Q2 2020's revenue was $3M; in Q1 2020, it was $4.2M; in Q4 2019, it was $2.4M; in Q3 2019, Wave's revenue was $2.9M.

Acquisitions

No recent acquisitions found related to Wave

Wave Funding History

$227.8M

Since Wave was founded in 2012, it has participated in 5 rounds of funding. In total Wave has raised $227.8M. Wave's last funding round was on Dec 2015 for a total of $30.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Dec 2015
$30M

Teva Pharmaceutical Industries

IPO
Nov 2015
$102M

Series B
Aug 2015
$66M
Series A
Feb 2015
$18M
Equity
Jan 2015
$11.8M
-

Total Funding: $227.8M

Since Wave was founded in 2012, it has participated in 5 rounds of funding. In total Wave has raised $227.8M. Wave's last funding round was on Dec 2015 for a total of $30.0M

Investments

No recent investments found related to Wave

Wave News

September 2, 2020Zolmax News

Analysts Anticipate Wave Life Sciences Ltd (NASDAQ:WVE) Will Announce Earnings of -$0.74 Per Share

Analysts expect that Wave Life Sciences Ltd (NASDAQ:WVE) will report ($0.74) earnings per share (EPS)... See more »
August 15, 2020Zolmax News

Wave Life Sciences Ltd (NASDAQ:WVE) to Post Q3 2020 Earnings of ($0.88) Per Share, Truist Securiti Forecasts

Wave Life Sciences Ltd (NASDAQ:WVE) - Research analysts at Truist Securiti boosted their Q3 2020 earn... See more »
August 10, 2020Zacks

Wave Life Sciences (WVE) Reports Q2 Loss, Lags Revenue Estimates

Wave Life Sciences (WVE) delivered earnings and revenue surprises of -11.65% and -57.00%, respectivel... See more »
August 10, 2020NewsOk

2Q Earnings Snapshot

SINGAPORE (AP) _ Wave Life Sciences Pte. Ltd.Read more on NewsOK.com... See more »
June 7, 2020Zolmax News

Wave Life Sciences (NASDAQ:WVE) Cut to Hold at BidaskClub

BidaskClub lowered shares of Wave Life Sciences (NASDAQ:WVE) from a buy rating to a hold rating in a ... See more »
April 24, 2020Reuters

Wave Life Sciences to return $7.2 mln PPP loan

Wave Life Sciences said on Friday it will return a $7.2 million loan granted under the Payroll Protec... See more »

Wave Press Releases

May 23, 2019GlobeNewswire

Wave Life Sciences to Present at the Jefferies 2019 Healthcare Conference

CAMBRIDGE, Mass., May 22, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-... See more »
May 10, 2019GlobeNewswire

Wave Life Sciences Reports First Quarter 2019 Financial Results and Provides Business Update

CAMBRIDGE, Mass., May 10, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-... See more »
April 16, 2019streetinsider

Wave Life Sciences Announces Suvodirsen Phase 1 Safety and Tolerability Data and Phase 2/3 Clinical Trial Design

Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage genetic medicines company committed to delive... See more »
April 10, 2019GlobeNewswire

Wave Life Sciences Provides Timing Update on PRECISION-HD Clinical Programs

Topline data readout from Huntington's disease clinical trials now expected by year end 2019Topline d... See more »
March 25, 2019GlobeNewswire

Wave Life Sciences to Present Suvodirsen Phase 1 Safety and Tolerability Data and Phase 2/3 Clinical Trial Design at the Muscular Dystrophy Association Clinical and Scientific Conference

CAMBRIDGE, Mass., March 25, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a clinica... See more »
March 6, 2019GlobeNewswire

Wave Life Sciences to Present at the Cowen 39th Annual Health Care Conference

CAMBRIDGE, Mass., March 06, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a clinica... See more »
May 9, 2018GlobeNewswire

Wave Life Sciences Reports First Quarter 2018 Financial Results and Provides Business Update

CAMBRIDGE, Mass., May 09, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ:WVE), a biotechnol... See more »

Headquarters

733 Concord Avenue

Cambridge, Massachusetts02138

1-617-949-2900

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Wave Life Sciences develops next-generation nucleic acid drugs that achieve high systemic bioavailability. Wave was founded in 2012. Wave's headquarters is located in Cambridge, Massachusetts, USA 02138. It has raised 227.8M in 5 rounds. The latest ro...

CEO

Wave's President & CEO, Paul Bolno, currently has an approval rating of 87%. Wave's primary competitors are Alnylam, Axolabs & Voyager Therapeutics.

Website

wavelifesciences.com

Frequently Asked Questions about Wave

  1. When was Wave founded?

    Wave was founded in 2012
  2. Who is Wave's CEO?

    Wave's CEO is Paul Bolno
  3. How much revenue does Wave generate?

    Wave generates $12.5M in revenue
  4. How much funding does Wave have?

    Wave has historically raised $227.8M in funding
  1. Where is Wave's headquarters?

    Wave's headquarters is in Cambridge Massachusetts, USA
  2. How many employees does Wave have?

    Wave has 250 employees
  3. What sector does Wave operate in?

    Wave is in Biotechnology, Pharmaceuticals
  4. Who are Wave's competitors?

    Wave's top competitors are Alnylam, Axolabs, Voyager Therapeutics